Sugi Predict

Sugi Predict / Compounds / SCHEMBL4204396

SCHEMBL4204396

SCHEMBL4204396

COc1ccc(N(Cc2cccnc2)c2ccc(S(=O)(=O)N3CCN(c4ccccn4)CC3)cc2)cc1OC1CCCO1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.51
▸ ALDH1A1 P00352 3/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ PDE4A P27815 2/20 0.43
▸ PDE4B Q07343 2/20 0.43
▸ PDE4C Q08493 2/20 0.43
▸ PDE4D Q08499 2/20 0.43
▸ KMT2A Q03164 7/20 0.42
▸ MEN1 O00255 6/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ NAMPT P43490 2/20 0.40
▸ LMNA P02545 3/20 0.39
▸ POLB P06746 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4195438 0.90 PDE4A (0.47) ALDH1A1L3MBTL1PDE4APDE4BPDE4C
SCHEMBL4200525 0.89 PDE4A (0.46) ALDH1A1L3MBTL1PDE4APDE4BPDE4C
SCHEMBL4193791 0.89 PDE4A (0.47) KDM4EALDH1A1HSD17B10L3MBTL1PDE4A
SCHEMBL4198510 0.88 PKM (0.47) ALDH1A1L3MBTL1PDE4APDE4BPDE4C
SCHEMBL4196632 0.88 PDE4A (0.47) KDM4EALDH1A1L3MBTL1PDE4APDE4B
SCHEMBL4192741 0.84 KMT2A (0.44) L3MBTL1PDE4APDE4BPDE4CPDE4D
SCHEMBL4206351 0.84 PDE4B (0.46) KDM4EALDH1A1L3MBTL1PDE4APDE4B
SCHEMBL4193474 0.84 PDE4B (0.48) ALDH1A1L3MBTL1PDE4APDE4BPDE4C
SCHEMBL4198462 0.83 PDE4B (0.54) KDM4EALDH1A1L3MBTL1PDE4APDE4B
SCHEMBL4204872 0.83 KMT2A (0.45) KDM4EHSD17B10L3MBTL1PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090048255-A1 PHOSPHODIESTERASE 4 INHIBITORS, INCLUDING N-SUBSTITUTED ANILINE AND DIPHENYLAMINE ANALOGS SCHUMACHER RICHARD A 2009-02-19 — — US claimed
US-20050119225-A1 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs MEMORY PHARMACEUTICALS CORP. (US) 2005-06-02 — — US claimed
US-20090048255-A1 PHOSPHODIESTERASE 4 INHIBITORS, INCLUDING N-SUBSTITUTED ANILINE AND DIPHENYLAMINE ANALOGS SCHUMACHER RICHARD A 2009-02-19 — — US disclosed
US-7405230-B2 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs MEMORY PHARMACEUTICALS CORPORATION (US) 2008-07-29 — — US disclosed
US-20050119225-A1 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs MEMORY PHARMACEUTICALS CORP. (US) 2005-06-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090048255-A1 PHOSPHODIESTERASE 4 INHIBITORS, INCLUDING N-SUBSTITUTED ANILINE AND DIPHENYLAMINE ANALOGS PDE4A, PDE4B, PDE3A KDM4E 156/4885ALDH1A1 221/4885HSD17B10 546/4885
US-20050119225-A1 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs PDE4A, PDE4B, PDE3A KDM4E 156/4885ALDH1A1 221/4885HSD17B10 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.